ENDO USA, Inc. recalls
Every recall we track for ENDO USA, Inc. — 11 in all, from 2024–2026 — plus the complaints and injury reports the public filed about them. 1 is rated “stop using now”.
Recalls per year, by danger level
11 recalls since 2017. 9% rated “stop using now”.
All FDA recall records for ENDO USA, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 4 | 0 | 5 |
| 2025 | 0 | 0 | 0 | 5 | 5 |
| 2026 (to date) | 0 | 0 | 0 | 1 | 1 |
What to do if you have a recalled ENDO USA, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All ENDO USA, Inc. recalls
5 shown- UnratedDrug
ENDO USA, Inc. recalls Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA,
Endo USA recalls 5x1mL Buprenorphine injections due to crystallization risk. Affected lots expire 02/2027 and 03/2027. Contact for return instructions.
Endo USAMar 13, 2026 - UnratedDrug
Endo USA, Inc. recalls Everolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured
Endo USA recalls 1,866 cartons of Everolimus tablets 7.5mg due to failed impurity specifications. Check lot numbers and expiration dates for affected units.
Endo USAOct 10, 2025 - UnratedDrug
Endo USA, Inc. recalls Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured
Endo recalls Everolimus 5mg tablets due to impurity IP-C failing specifications. Rx-only product with specific lot number. Contact for return instructions.
EndoSep 5, 2025 - Stop using nowDrug
ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed
ENDO USA recalls 44,397 vials of Adrenalin Chloride Solution because the label is misleading and resembles FDA-approved Epinephrine Injection.
ENDO USADec 20, 2024 - Lower riskDrug
Endo USA, Inc. recalls Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards
Endo USA recalls 0.125 mg Clonazepam orally disintegrating tablets with incorrect labeling. Some cartons show wrong strength but blister strips indicate correct dosage. No action needed as the error is not dangerous.
EndoNov 18, 2024
ENDO USA, Inc. recall questions
How many recalls has ENDO USA, Inc. had?
11 recalls from ENDO USA, Inc. are on record with U.S. safety agencies, from 2024–2026.
What is the most recent ENDO USA, Inc. recall?
ENDO USA, Inc. recalls Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA,, dated Mar 13, 2026. Every ENDO USA, Inc. recall is listed on this page, newest first.
What should I do if I have a recalled ENDO USA, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new ENDO USA, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.